Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New screening approach could help kids at risk for bipolar disorder

NCT ID NCT07622927

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new way to help families decide if their children should be screened for early signs of mental health problems. The children are ages 7 to 21 and have a parent with bipolar disorder. The researchers are creating a video and FAQ to help parents understand the risks and make informed choices. They will also test if remote screening is practical and acceptable for these families.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to better tools for early detection of mental health issues in children at risk for bipolar disorder, potentially allowing for earlier support and intervention.
What could go wrong
This is an early-stage observational study focused on developing and testing screening tools, not a treatment trial. The results may not directly improve outcomes, and the screening tools may not be widely adopted or effective in all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The following groups are being targeted for this observational study: 1. Parents (age 18 or older) who have ever been diagnosed with bipolar disorder and have a biological child between the ages of 7-21 2. Caregivers (age 18 or older) who are primarily responsible for a child between the ages of 7-21 whose biological parent has a lifetime diagnosis of bipolar disorder 3. Youth (ages 7-21) without bipolar disorder, but has at least 1 biological parent with a lifetime diagnosis of bipolar disorder

Ages

7 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for Group A - Parent with Bipolar Disorder: 1. Age: 18 years or older. 2. Confirmation of a lifetime Bipolar I or II diagnosis 3. Parent status: Has at least one biological child aged 7-21 years. 4. Capacity and willingness to consent: Able and willing to provide informed consent. 5. Study participation: Able to comply with study procedures (e.g., co-design sessions, interviews, assessments). 6. Language: Able to read, speak, and understand English. Inclusion Criteria for Group B - Adult Caregiver: 1. Age: 18 years or older. 2. Caregiver status: The adult primarily responsible for the daily care and/or medical decisions for ≥ 6 months for a child aged 7-21 years whose biological parent has a lifetime, clinician-confirmed diagnosis of Bipolar I or II disorder. 3. Capacity and willingness to consent: Able and willing to provide informed consent. 4. Study participation: Able to comply with study procedures (e.g., co-design sessions, interviews, assessments). 5. Language: Able to read, speak, and understand English. Inclusion Criteria for Group C - At-Risk Youth: 1. Age: 1. Phase 1 (co-design) and Phase 2A (alpha testing): 13-18 years 2. Phase 2B (beta testing): 13-18 years 3. Phase 3 (screening): 7-21 years 2. Diagnosis status: Must not have a current diagnosis of Bipolar I or II disorder. 3. Parental diagnosis: Has at least 1 biological parent with a lifetime, clinician-confirmed Bipolar I or II diagnosis (as defined in Groups A and B). 4. Consent/Assent: 1. For youth aged 18-21: Able and willing to provide informed consent (verbal) 2. For youth aged 7-21: Parent/guardian/LAR able and willing to provide informed consent (verbal) and youth able to provide assent (verbal) 5. Participant ability: Able and willing to participate in study activities (e.g., co-design discussions, questionnaires, or screening assessments. 6. Language: English sufficient to comprehend study procedures and materials. Criteria for Exclusion of Participants A potential participant will NOT be eligible for participation in this study if any of the following criteria are met: 1. Unable to provide informed consent due to cognitive impairment or language barriers 2. Experiencing acute psychiatric instability at enrollment (e.g., acute psychosis or acute suicidality without stabilization) 3. Has a medical or psychiatric condition that, in the judgment of the Principal Investigator or study clinician, would place undue risk on the individual or interfere with standard clinical care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bipolar disorder (BD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • UT Southwestern Medical Center

    RECRUITING

    Dallas, Texas, 75390, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.